A promising new treatment for refractory aplastic anemia

New England Journal of Medicine

Volumn 367, Issue 1, 2012, Pages 74-75

  Metcalf, Donald ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ELTROMBOPAG; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMATOLOGIC AGENT; INTERFERON; NONPEPTIDE AGONIST; PEPTIDE AGONIST; THROMBOPOIETIN; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; BONE MARROW CELL; CELL LINEAGE; CELL MATURATION; CELL STIMULATION; DISEASE CONTROL; DISEASE SEVERITY; DRUG MECHANISM; EDITORIAL; HEMATOPOIETIC STEM CELL; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOTHERAPY; MEGAKARYOPOIESIS; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE COUNT; TREATMENT DURATION;

EID: 84863510682     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1204395     Document Type: Editorial

References (9)

1. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006;108:2509-19.
2. Bacigalupo A. Treatment strategies for patients with severe aplastic anemia. Bone Marrow Transplant 2008;42:Suppl 1:S42-S44.
3. Gurion R, Gafter-Gvili A, Paul M, et al. Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy - systematic review and meta-analysis. Haematologica 2009;94:712-9.
4. Kimura S, Roberts AW, Metcalf D, Alexander WS. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc Natl Acad Sci U S A 1998;95:1195-200. (Pubitemid 28124935)
5. de Graaf CA, Metcalf D. Thrombopoietin and hematopoietic stem cells. Cell Cycle 2011;10:1582-9.
6. Erickson-Miller CL, Delorme E, Tian SS, et al. Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist. Stem Cells 2009;27:424-30.
7. Bussel JB, Cheng G, Saleh MN, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007;357:2237-47. (Pubitemid 350190754)
8. Olnes MJ, Scheinberg P, Calvo KR, et al. Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med 2012;367:11-9.
9. Walne AJ, Dokal A, Plagnol V, et al. Exome sequencing identifies MPL as a causative gene in familial aplastic anemia. Haematologica 2012;97:524-8.